Dr. Michael T. Caire, MD

Dr. Caire practices at Manatee Surgical Center in Bradenton, Florida.

Dr. Caire's NPI, 1770802134, was assigned on May 25, 2010. Dr. Caire graduated from USF Health Morsani College of Medicine in 2010. Dr. Caire holds Florida license ME117430.

Dr. Caire's primary practice is Manatee Surgical Center, at 601 Manatee Ave W, Bradenton, FL 34205. The practice phone is (941) 745-2727.

Dr. Caire's primary practice is Manatee Surgical Center in Bradenton, Florida. Dr. Caire is also affiliated with Lakewood Ranch Medical Center. The medical group on file is Florida Digestive Health Specialists. Dmand AI also links Dr. Caire to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caire practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Caire's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Caire is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Caire's licenses on file in 3 states: Florida, New York and Virginia.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Caire treats.

CMS data shows 12,194 Medicare services from Dr. Caire across 17 procedure codes in 2024, for 603 Medicare patients. Medicare paid $319,687 for them.

CMS counts 603 Medicare patients who saw Dr. Caire in 2024. The largest group is 65 to 74, with 265 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Caire's median patient age at 67, with 52% women.

In 2024, Dr. Caire wrote 1,495 Medicare Part D claims for 567 patients. 75% of them were for generic drugs. CMS names the drug for 1,330 of them, across 19 drugs with 11 or more claims each, at $448,911 in total drug cost. In 2023, CMS named 1,135 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Caire for performance year 2024, reported as part of a group. Dr. Caire accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Caire as offering telehealth. CMS counts 357 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Caire, more than 97% of the clinicians it reports for that procedure.

CMS Open Payments shows 337 general payments to Dr. Caire from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $1,608.

Dr. Caire graduated from USF Health Morsani College of Medicine in 2010.

Dr. Caire is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.